[1] |
Gower AC, Steiling K, Brothers JF 2nd, et al. Transcriptomic studies of the airway field of injury associated with smokingrelated lung disease[J]. Proc Am Thorac Soc, 2011, 8(2): 173-9.
|
[2] |
Au WW, Su D, Yuan J. Cigarette smoking in China: public health, science, and policy[J]. Rev Environ Health, 2012, 27(1): 43-9.
|
[3] |
Wu X, Chen H, Wang X. Can lung cancer stem cells be targeted for therapies? [J]. Cancer Treat Rev, 2012, 38(6): 580-8.
|
[4] |
Wang Q, Wang S, Wang H, et al. MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment[J]. Exp Biol Med (Maywood), 2012, 237(3): 227-35.
|
[5] |
He B, Yin B, Wang B, et al. MicroRNAs in esophageal cancer (Review)[J]. Mol Med Rep, 2012, 6(3): 459-65.
|
[6] |
Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13 q14 in chronic lymphocytic leukemia[J]. Proc Natl Acad Sci U S A, 2002, 99(24): 15524-9.
|
[7] |
Saus E, Soria V, Escaramís G, et al. Genetic variants and abnormal processing of pre-miR-182, a circadian clock modulator, in major depression patients with late insomnia[J]. Hum Mol Genet, 2010, 19 (20): 4017-25.
|
[8] |
Cai Y, Yu X, Hu S, et al. A brief review on the mechanisms of miRNA regulation[J]. Genomics Proteomics Bioinformatics, 20 09, 7(4): 147-54.
|
[9] |
Fabbri M, Bottoni A, Shimizu M, et al. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia[J]. JAMA, 2011, 30 5(1): 59-67.
|
[10] |
Zhang J, Ma L. MicroRNA control of epithelial-mesenchymal transition and metastasis[J]. Cancer Metastasis Rev, 2012, 31 (3-4): 653-62.
|
[11] |
Xu XM, Qian JC, Deng ZL, et al. Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer[J]. Oncol Lett, 2012, 4(2): 339-45.
|
[12] |
Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression[J]. Cancer Cell, 2008, 13(6): 49 6-506.
|
[13] |
Xie L, Ushmorov A, Leithäuser F, et al. FOXO1 is a tumor suppressor in classical Hodgkin lymphoma[J]. Blood, 2012, 11 9(15): 3503-11.
|
[14] |
Sun Y, Fang R, Li C, et al. Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro[J]. Biochem Biophys Res Commun, 2010, 396(2): 501-7.
|
[15] |
Guan P, Yin Z, Li X, et al. Meta-analysis of human lung cancer microRNA expression profi ling studies comparing cancer tissues with normal tissues[J]. J Exp Clin Cancer Res, 2012, 31: 54.
|
[16] |
Liu Z, Liu J, Segura MF, et al. MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma[J]. J Pathol, 2012, 228(2): 204-15.
|
[17] |
Alshalalfa M, Bader GD, Goldenberg A, et al. Detecting microRNAs of high influence on protein functional interaction networks: a prostate cancer case study[J]. BMC Syst Biol, 2012, 6: 112.
|
[18] |
Weeraratne SD, Amani V, Teider N, et al. Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma[J]. Acta Neuropathol, 2012, 12 3(4): 539-52.
|
[19] |
Kong WQ, Bai R, Liu T, et al. MicroRNA-182 targets cAMPresponsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma[J]. FEBS J, 2012, 279(7): 12 52-60.
|
[20] |
Poell JB, van Haastert RJ, de Gunst T, et al. A functional screen identifies specific microRNAs capable of inhibiting human melanoma cell viability[J]. PLoS One, 2012, 7(8): e43569.
|
[21] |
Rawe VY, Payne C, Schatten G. Profi lin and actin-related proteins regulate microfilament dynamics during early mammalian embryogenesis[J]. Hum Reprod, 2006, 21(5): 1143-53.
|
[22] |
Sagot I, Rodal AA, Moseley J, et al. An actin nucleation mechanism mediated by Bni1 and profi lin[J]. Nat Cell Biol, 2002, 4( 8): 626-31.
|
[23] |
Zou L, Ding Z, Roy P. Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation[J]. J Cell Physiol, 2010, 223(3): 623 -9.
|